Brenus Pharma vs Umlaut.bio
Brenus Pharma vs Umlaut.bio, compared side by side on 13 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Brenus Pharma is on 48/100 and Umlaut.bio on 35/100.
Where each one leads
Brenus Pharma
- our overall score: 48/100 against 35/100
- funding raised: $12.6M against $3.0M
Umlaut.bio
Leads on none of the measures we hold for both companies.
At a glance
| Measure | Brenus Pharma | Umlaut.bio |
|---|---|---|
| What it is | Clinical-stage immunotherapy company developing novel treatments for cancer. | Developing novel immunotherapies for cancer. |
| Category | Biotechnology, Pharmaceuticals, Healthcare, Biotech | Biotechnology, Cancer, Immunotherapy, Drug Discovery |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Platform |
| Founded | Not published | 2022 |
| Headquarters | Lyon, France | Cambridge, USA |
| Status | Active | Active |
Size, funding and growth
| Measure | Brenus Pharma | Umlaut.bio |
|---|---|---|
| Employees | 29 | Not published |
| Total funding | $12.6M | $3.0M |
| Latest round | Series A | Pre-Seed |
| LinkedIn followers | 6,500 | Not published |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Brenus Pharma | Umlaut.bio |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 48/100 | 35/100 |
| Traction | 50/100 | 32/100 |
| Search visibility | 31/100 | 8/100 |
| Quality | 62/100 | 48/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (36/100) | F (37/100) |
| Domain ratingLink authority, 0-100 | Not published | 7/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Brenus Pharma | Umlaut.bio |
|---|---|---|
| Hosting | Not detected | Self Managed |
Brenus Pharma vs Umlaut.bio: common questions
Which is better, Brenus Pharma or Umlaut.bio?
On our 0-100 score Brenus Pharma rates higher (48/100 against 35/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 13 data points above: read the rows that match what you are buying for.
How do Brenus Pharma and Umlaut.bio compare on the numbers?
Brenus Pharma leads on our overall score (48/100 against 35/100), funding raised ($12.6M against $3.0M).
Read the full Brenus Pharma review and pricing or the Umlaut.bio review and pricing. You can also browse other Brenus Pharma alternatives we track.